drugset / Trial / NCT01178099
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to measure the exposure to prasugrel's active metabolite and the pharmacodynamic effects of prasugrel treatment in people with Sickle Cell Disease (SCD).
Timeline
- Start
- 2010-07
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prasugrel | Small molecule | 5 mg | Oral |
| Subject | Prasugrel | Small molecule | 7.5 mg | Oral |